Westchester Capital Management (New York)’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Westchester Capital Management (New York)’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-655,044	Closed	-$7.32M	–	540
2022 Q4	$7.32M	Buy	+655,044	New	+$6.35M	0.2%	118

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Westchester Capital Management (New York)'s OYST Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 655,044 shares — an estimated $7.32M sold.

Westchester Capital Management (New York) first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $7.32M in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Westchester Capital Management (New York) reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 655,044 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $7.32M.
Westchester Capital Management (New York) first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Westchester Capital Management (New York)'s Oyster Point Pharma, Inc. Common Stock position peaked at $7.32M in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.